Stopping Levothyroxine in Subclinical Hypothyroidism Safe, Feasible Stopping Levothyroxine in Subclinical Hypothyroidism Safe, Feasible
Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism. Study helps fill a data gap on discontinuation.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Drugs & Pharmacology | Endocrinology | Hypothyroidism | Levothyroxine | Study | Synthroid